Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesley Hayes

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Frontiers in Pediatrics|March 3, 2020
The Incidence of Paediatric Acute Kidney Injury Identified Using an AKI E-Alert Algorithm in Six English HospitalsSheetal Bhojani, Jelena Stojanovic, Nabil Melhem, et al.
Frontiers in Pediatrics|October 2, 2024
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trialYaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, et al.
BMJ Open|March 15, 2022
Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO)Wesley Hayes, Emma Laing, Claire Foley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2025
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary HyperoxaluriaYaacov Frishberg, Jaap W Groothoff, Sally-Anne Hulton, et al.
The Lancet. Diabetes & Endocrinology|April 27, 2026
Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised studyAgnès Linglart, Francesco Emma, Justine Bacchetta, et al.
Pediatric Nephrology (Berlin, Germany)|August 1, 2022
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trialWesley Hayes, David J Sas, Daniella Magen, et al.
NIHR Open Research|February 23, 2026
Empirical oral AntibioticS for possible UTI in well appearing Young febrile infants (EASY)Thomas Waterfield, Ronan McMullan, Mark D Lyttle, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young childrenDavid J Sas, Daniella Magen, Wesley Hayes, et al.
BMJ Open|June 10, 2026
Randomised multiple centre trial of conservative versus liberal fluid administration for children receiving a kidney transplant (LIMITS): clinical trial protocolNuala D M Calder, Fotini Kaloyirou, James Griffiths, et al.
Pediatric Nephrology (Berlin, Germany)|November 4, 2015
Positive trends in paediatric renal biopsy service provision in the UK: a national survey and re-audit of paediatric renal biopsy practiceAsheeta Gupta, Joanna Campion-Smith, Wesley Hayes, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Frontiers in Pediatrics|March 3, 2020
The Incidence of Paediatric Acute Kidney Injury Identified Using an AKI E-Alert Algorithm in Six English HospitalsSheetal Bhojani, Jelena Stojanovic, Nabil Melhem, et al.
Frontiers in Pediatrics|October 2, 2024
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trialYaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, et al.
BMJ Open|March 15, 2022
Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO)Wesley Hayes, Emma Laing, Claire Foley, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2025
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary HyperoxaluriaYaacov Frishberg, Jaap W Groothoff, Sally-Anne Hulton, et al.
The Lancet. Diabetes & Endocrinology|April 27, 2026
Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised studyAgnès Linglart, Francesco Emma, Justine Bacchetta, et al.
Pediatric Nephrology (Berlin, Germany)|August 1, 2022
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trialWesley Hayes, David J Sas, Daniella Magen, et al.
NIHR Open Research|February 23, 2026
Empirical oral AntibioticS for possible UTI in well appearing Young febrile infants (EASY)Thomas Waterfield, Ronan McMullan, Mark D Lyttle, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young childrenDavid J Sas, Daniella Magen, Wesley Hayes, et al.
BMJ Open|June 10, 2026
Randomised multiple centre trial of conservative versus liberal fluid administration for children receiving a kidney transplant (LIMITS): clinical trial protocolNuala D M Calder, Fotini Kaloyirou, James Griffiths, et al.
Pediatric Nephrology (Berlin, Germany)|November 4, 2015
Positive trends in paediatric renal biopsy service provision in the UK: a national survey and re-audit of paediatric renal biopsy practiceAsheeta Gupta, Joanna Campion-Smith, Wesley Hayes, et al.
Pageof 6